Zai Lab Ltd

We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States. We focus on discovering, developing, and commercializing products for medical conditions with significant unmet needs in oncology, immunology, neuroscience, and infectious disease. Our experienced team has formed partnerships with leading global biopharmaceutical companies, resulting in a broad pipeline that includes multiple commercial products and multiple programs in late-stage clinical development. We also have an in-house research and development team with strong product discovery and translational research capabilities, and we are developing a pipeline of proprietary product candidates with global rights. Our mission is to be a leading global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies that improve the lives of patients. To achieve this, our strategy involves three pillars: accelerating medicines to patients by investing in research and development, expanding and strengthening our global and regional pipelines through internal discovery and collaborations, and continuing our commercial excellence and execution by increasing access to existing commercial products and improving efficiency as we prepare for new product launches or new indications for existing products.